期刊文献+

VEGF在乳腺癌组织中的表达及其临床意义 被引量:4

下载PDF
导出
摘要 目的研究乳腺癌中VEGF的表达与临床病理指标之间的关系,探讨VEGF在乳腺癌发生发展中的作用。方法应用免疫组化检测50例乳腺癌组织中VEGF的表达,同时分析乳腺癌中VEGF表达与临床病理指标之间的关系。结果乳腺癌中VEGF的阳性表达率为72%。显著高于对照组的6%阳性表达。在有淋巴结转移的乳腺癌中的阳性表达率明显高于无淋巴结转移者(P<0.05),随着临床分期的增高,VEGF的阳性表达率也明显增高,差异有统计学意义(P<0.05)。结论 VEGF可能参与了乳腺癌的进展,是乳腺癌侵袭性的一个标记物。检测乳腺癌中VEGF表达可有助于预测乳腺癌的生物学行为。
出处 《中外医疗》 2013年第35期65-66,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献12

  • 1史淑红,刘英丽,教伟,孟庆玲.乳腺癌中Livin的表达与癌细胞凋亡相关性的研究[J].现代肿瘤医学,2009,17(12):2320-2323. 被引量:5
  • 2Oliveria VM,Aldrighi JM,Bagnoli F. Evidence of the action of bisphosphonates in the prevention of breast cancer[J].{H}Revista da Associacao Medica Brasileira,2013,(01):7-8.
  • 3Ran S. Lymphangiogenesis and lymphatic metastasis in breast cancer[J].{H}PATHOPHYSIOLOGY,2010,(04):229-251.
  • 4Cohen V,Zetser A. Heparanase induces VEGF-C and facilitates tumor lymphangiogenesis[J].{H}International Journal of Cancer,2013,(01):2566-2273.
  • 5Schoppmann SF,Tamandl D,Roberts L. HER2/neu expression correlates with vascular endothelial growth factor-c and lymphangiogenesis in lymph node-positive breast cancer[J].{H}ANNALS OF ONCOLOGY,2010,(05):955-960.
  • 6Kinoshita J. Clinical significance of vascular endothelial growth factor in breast cancer[J].{H}Breast Cancer Research and Treatment,2013,(02):159-161.
  • 7Derleth C. Aniangiogenic therapies in early-stage breast cancer[J].Clin Breast Cancer,2010,(01):E23-E31.
  • 8Das S,Ladell DS. Vascular endothelial growth factor indrces lymphangitic carcinomatosis,an extremely aggressive form of lung metastases[J].Cancer Res,2013,(05):1814-1824.
  • 9Vesuna F,van Didst P,Chen JH. Twist is a transcriptional repressor of VEGF expression in breast cancer[J].{H}Biochemical and Biophysical Research Communications,2008,(02):235.
  • 10Linderholm BK,Gruvberger Saal S. Vascrlar endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymphnode negative breast cancer[J].{H}BREAST,2008,(05):484-491.

二级参考文献22

  • 1吕建,陈智超.Livin与肿瘤研究新进展[J].中华肿瘤防治杂志,2006,13(17):1347-1350. 被引量:13
  • 2Kasof GM, Comes BC. Livin, a novel inhibitor of apoptosis protein family member [ J ]. J Biol Chem,2001,276 ( 5 ) :3238 - 3246.
  • 3Vucic D,Stermicke HR,Pisabarro MT,et al. ML- IAP,a novel inhibitor of apoptosis that is preferentially expressed in human melanomas[ J]. Curr Biol,2000,10 ( 21 ) : 1359 - 1366.
  • 4Lin JH, Deng G, Huang Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family[ J]. Biochem Biophys Res Commun ,2000 ,279 ( 3 ) :820 - 831.
  • 5Ashhab Y,Alian A,Polliack A,et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[ J]. FEBS Lett, 2001,495 ( 1 - 2 ) :56 - 60.
  • 6Sanna MG, da Silva Correia J , Ducrey O, et al. IAP suppression of apoptosis involves distinct mechanisms:the TAK1/JNK1 signaling cascade and caspase inhibition [ J ]. Mol Cell Biol, 2002,22 ( 6 ) : 1754 - 1766.
  • 7Liu B,Han M,Wen JK,et al. Livin/ML- IAP as a new target for cancer treatment [ J]. Cancer Lett ,2007 ,250 (2) : 168 - 176.
  • 8Chang H, Schimmer AD. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy[J]. Mol Cancer Ther,2007,6( 1 ) :24 -30.
  • 9Gordon GJ, Mani M, Mukhopadhyay L, et al. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma [ J ]. J Pathol, 2007,211 ( 4 ) :447 - 454.
  • 10Nachmias B, lazar I, Elmalech M, et al. Subcellular localization determines the delicate balance between the anti - and pro - apoptotic activity of Livin [ J ]. Apoptosis, 2007,12 ( 7 ) : 1129 - 1142.

共引文献8

同被引文献27

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部